Corporate Profile
Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.
AURA BIOSCIENCES
October 29, 2024 5:25 AM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.